Group A subjects must have measurable or evaluable disease per the appropriate disease criteria.
Subjects must have evaluable disease for the dose escalation, and measurable disease for the dose expansion.
Subjects must have measurable or evaluable disease
Subjects must have either measurable and/or evaluable disease
Subjects must have either measurable or evaluable disease
Subjects must have either measurable or evaluable disease
Subjects should have measurable or evaluable disease
Subjects may have measurable or non measurable but evaluable disease; subjects with surgically resected locally advanced or metastatic disease at high risk of relapse are also eligible
Patients must have measurable or evaluable disease (subjects with elevation of tumor marker with no evidence of disease on imaging or exam are not eligible)
Subjects need to have evaluable disease (measurable or not measurable).
Subjects do not need to have measurable or evaluable disease; chemotherapy may be administered in the neoadjuvant, adjuvant, or metastatic setting
